Further details about the patient groups' parallel session at the 65th World Health Assembly (WHA): the International Alliance of Patients’ Organizations (IAPO), Alzheimer’s Disease International (ADI), the Multiple Sclerosis International Federation (MSIF), Thalassaemia International Federation (TIF), and the World Hepatitis Alliance (also acronymed WHA) will hold a side meeting entitled 'Patient-Centred Indicators for the Prevention and Control of Non-Communicable Diseases (NCDs)'. The venue is Room IX (9), Palais des Nations, United Nations, Geneva, Switzerland. The date and time: Monday, 21st May 2012, 5.30pm-7.00pm.
IAPO's 'Statement on the Prevention and Control of NCDs' can be read at http://www.whcaonline.org/uploads/WHA2012FINAL.pdf, page 36.

The UK-based Hepatitis C Trust has formed a partnership with Addaction, the UK’s largest drug treatment charity. The Trust is to provide a nationwide training programme to increase awareness of hepatitis C (and to strengthen care pathways) among the people with addiction problems who are familiar to Addaction. At least 2,000 individuals at risk are expected to be tested for hepatitis C during the course of the project, with 90% of those found to be positive likely to be referred to specialist secondary care. Simon Antrobus, CEO of Addaction said: “Addaction is committed to addressing hepatitis C, as, in our experience, it is a major barrier to the full recovery of people with a history of drug use. We feel that combining our expertise with that of the Trust will help overcome the barrier, and will help a great number of people lead happy and healthy lives”.  Charles Gore, CEO of the Hepatitis C Trust, and President of the World Hepatitis Alliance (WHA), said: “We are excited to be working in partnership with such a large organisation as Addaction. This is an enormous opportunity to reach thousands of people at risk of hepatitis C. With so many people yet to be diagnosed in the UK, this partnership could make a major difference”.